These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29072619)

  • 1. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
    Mphahlele MJ; Gildenhuys S; Parbhoo N
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.
    Wang L; Li P; Li B; Wang Y; Li J; Song L
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28956845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
    Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
    Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
    He J; Wang X; Zhao X; Liang Y; He H; Fu L
    Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives.
    Khodair AI; Alsafi MA; Nafie MS
    Carbohydr Res; 2019 Dec; 486():107832. PubMed ID: 31622868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Disubstituted Quinazoline Derivatives Act as Inducers of Tubulin Polymerization: Synthesis and Cytotoxicity.
    Moghadam ES; Tehrani MH; Csuk R; Fischer L; Faramarzi MA; Rashidi A; Javadi I; Amini M
    Anticancer Agents Med Chem; 2019; 19(8):1048-1057. PubMed ID: 30868963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
    Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
    Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity.
    Pathak P; Shukla PK; Kumar V; Kumar A; Verma A
    Inflammopharmacology; 2018 Dec; 26(6):1441-1453. PubMed ID: 29663100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents.
    Devegowda PS; Balaji KS; Prasanna DS; Swaroop TR; Kameshwar VH; Jayarama S; Siddalingaiah L; Rangappa KS
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1931-1941. PubMed ID: 28403784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
    Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
    Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.
    OuYang Y; Zou W; Peng L; Yang Z; Tang Q; Chen M; Jia S; Zhang H; Lan Z; Zheng P; Zhu W
    Eur J Med Chem; 2018 Jun; 154():29-43. PubMed ID: 29775935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, One Pot Synthesis and Molecular Docking Studies of Substituted-1H-Pyrido[2,1-b] Quinazolines as Apoptosis-Inducing Anticancer Agents.
    Bathula R; Satla SR; Kyatham R; Gangarapu K
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):411-421. PubMed ID: 32102519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
    El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
    Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
    Guda R; Narsimha S; Babu R; Muthadi S; Lingabathula H; Palabindela R; Yellu NR; Kumar G; Kasula M
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5517-5523. PubMed ID: 27769618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors.
    Tu Y; Wang C; Xu S; Lan Z; Li W; Han J; Zhou Y; Zheng P; Zhu W
    Bioorg Med Chem; 2017 Jun; 25(12):3148-3157. PubMed ID: 28428040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.